Curt McCandless

Curt McCandless is an experienced consultant and sales specialist in the pharmaceutical industry, currently serving as an Ultra Rare Disease Consultant-Dermatology at Boehringer Ingelheim since April 2022 and as a Senior Rare Disease Specialist at QOL Medical LLC since February 2020. Prior roles include Professional Oncology Sales Representative at Syneos Health, where responsibilities included promoting treatments for oncology settings, and Territory Manager at Actelion, focusing on Valchlor for Cutaneous T-Cell Lymphoma. McCandless began their career at Merck as an Executive Sales Representative in Virology, contributing to the launch of multiple antiviral therapies. McCandless holds a Master of Arts in Public Policy Administration from Saint Louis University and a Bachelor's Degree in Business Administration from Southern Illinois University Edwardsville.